Increased numbers of tumor-infiltrating mature DCs and activated CD8+ T cells were observed in mice treated with OVV-hNbTIM3 compared to mice treated with OVV control, either in Raji models (Fig. 6E) or MDA-MD-231 models (Fig. 6F). This evidence concerns the gene CD8A and neoplasm.